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Abstract
Genetic Analysis Workshop 14 simulated data have been analyzed with MASC(marker association
segregation chi-squares) in which we implemented a bootstrap procedure to provide the variation
intervals of parameter estimates. We model here the effect of a genetic factor, S, for Kofendrerd
Personality Disorder in the region of the marker C03R0281 for the Aipotu population. The
goodness of fit of several genetic models with two alleles for one locus has been tested. The data
are not compatible with a direct effect of a single-nucleotide polymorphism (SNP) (SNP 16, 17, 18,
19 of pack 153) in the region. Therefore, we can conclude that the functional polymorphism has
not been typed and is in linkage disequilibrium with the four studied SNPs. We obtained very large
variation intervals both of the disease allele frequency and the degree of dominance. The
uncertainty of the model parameters can be explained first, by the method used, which models
marginal effects when the disease is due to complex interactions, second, by the presence of
different sub-criteria used for the diagnosis that are not determined by S in the same way, and third,
by the fact that the segregation of the disease in the families was not taken into account. However,
we could not find any model that could explain the familial segregation of the trait, namely the
higher proportion of affected parents than affected sibs.
Background
The aim of this work is to study and model the marginal
effect of one susceptibility locus involved in the determin-
ism of Kofendrerd Personality Disorder (KPD) in the
Aipotu population. The presence of a susceptibility locus
closely linked to the marker C03R0281 was shown by the
existence of both strong association and genetic linkage
between this marker and the trait [1,2]. Before modeling
the marginal effect of this factor, we searched for the rep-
licate that best represented this effect. The modeling (esti-
mation of the allele frequency and marginal penetrances)
is carried out through the MASC method [3], using the
information provided by the marker C03R0281 denoted
M hereafter. The variation intervals for the parameter esti-
mates are obtained through a bootstrap procedure we
incorporated in the MASC (marker association segrega-
tion chi-squares) program.
Methods
Selection of the best replicate
We want to select the replicates that best represent the dis-
tributions in the region of marker M (C03R0281) in terms
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of both association and linkage. Estimating the parame-
ters and their variation intervals in this sample is then
equivalent to evaluating them in the whole set of repli-
cates. In the pooled sample set (10,000 families), we con-
sider one index (an affected case) by family and his
genotype for the marker M. For each index, we also con-
sider his identity-by-descent (IBD) sharing for M with one
random affected sib (families of the Aipotu population
have been selected as having at least two sibs affected with
KPD). In order to have a reliable IBD sharing for each sib
pair, we ordered one SNP packet (153) surrounding
marker M. The IBD sharing is obtained by maximum like-
lihood estimation using the information provided by the
whole set of markers in the M region on chromosome 3.
Figure 1 gives the genotype distribution of the 10,000
index cases for the marker M. The two alleles of M, M1 and
M2, have a frequency of 0.56 and 0.44, respectively. For
each marker genotype, the index cases are classified
according to their IBD sharing with one affected sib (strat-
ified IBD distribution).
Because we are looking for the model that best explains
these four independent distributions (one genotype dis-
tribution and three stratified IBD distributions), we first
determined the replicates that best reflect these distribu-
tions. We computed the distance of each of the 100 repli-
cates to the pooled sample by a chi-square statistics, equal
to the sum of the four independent chi-squares obtained
by comparing the distributions observed in the replicate
and in the pooled sample.
Modeling the genetic effect
We modeled the effect of the susceptibility factor by the
MASC method. For a given genetic model, the MASC
method computes the four expected distributions
described in Figure 1 and the previously described chi-
square statistics (the sum of four chi-squares between the
observed and expected distributions). The chi-square is
minimized over the parameters left free to vary. The fit of
the model to the observed data is then tested (8 df minus
the number of parameters free to vary). The parameters of
the genetic model are the penetrances of each genotype
and the coupling between the marker alleles and the sus-
ceptibility factor alleles. The expected distributions are
computed conditionally to the fact that the index cases
have at least one affected sib. They depend on the fre-
quency of the marker alleles in the general population.
The marker allele frequencies may be assumed to be
already known (situation 1), to be obtained through a
control sample (situation 2), or to be obtained through
the parental alleles which have not been transmitted to
the affected cases used for the family ascertainment (situ-
ation 3).
Computing the intervals of variation for the parameter 
estimates
We implemented a bootstrap procedure for calculating
the variation intervals of the parameter estimates in the
MASC program. The uncertainty on the parameters is due
to the sampling of families and of controls, when the
marker allele frequencies are inferred from a control sam-
ple. For each bootstrapped family set (1,000 replicates),
we estimated the parameters considering the three possi-
bilities described above for the marker allele frequencies.
In situation 1, there is no uncertainty induced by the
marker allele frequencies. In situation 2, the bootstrap
procedure is applied to both the family sample and a sam-
ple of 50 controls randomly drawn among the 100 con-
trol samples. In situation 3, the bootstrap is only applied
to the family sample. For the three situations, we obtain




Table 1 gives the ten replicates that best represent the dis-
tributions in the marker M area (the smallest chi-squares).
Replicate 97 was chosen for the following analyses.
Modeling of the genetic effects
We tested a biallelic susceptibility locus model (S1, S2)
and estimate four parameters: 2 relative penetrances, λ1
and λ2, and 2 coupling probabilities, c11and c12, where
λ1 = P(affected | S1S2) / P(affected | S1S1),
Distribution of the marker C03R0281 for the 10,000 index  cases of the Aipotu population Figure 1
Distribution of the marker C03R0281 for the 10,000 
index cases of the Aipotu population. The first level 
shows the genotype distribution of the 10,000 index cases 
for the marker M. The second level shows, for each marker 
genotype, the index cases classified according to their IBD 
sharing with one affected sib (stratified IBD distribution).BMC Genetics 2005, 6:S87
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λ2 = P(affected | S2S2) / P(affected | S1S1),
c11 = P(S1 | M1),
c12 = P(S1 | M2).
The frequency (q) of allele S1 at the susceptibility locus
can be written as
q = P(S1) = c11 P(M1) + c12 P(M2).
The direct effect of marker M, which means S1 is con-
founded with M1, and S2 with M2, was rejected (χ2 =
14.14; 6 df).
However, many biallelic models are not rejected. We give
several models compatible with the observations made on
M in replicate 97 (Table 2). To discriminate between these
models, we looked for those that also fit the observations
on the closely linked markers. Among these markers, three
in packet 153 were also associated with KPD: SNPs 16, 17,
and 18 (results shown in Table 3). The direct effect of SNP
16, 17, or 18 was also rejected and these three SNPs were
not significantly in linkage disequilibrium (LD) with each
other or with marker M (SNP 19). We therefore concluded
that the functional polymorphism has not been typed and
is in LD with the four studied SNPs.
Computing the variation intervals of the parameter 
estimates
Table 4 gives the 95% variation intervals of the disease
allele frequency q. The intervals are given assuming uncer-
tainty or not on the allele frequencies of marker M.
Because the results are very close using a sample of 50 con-
trols or the untransmitted alleles of the 100 families, only
results for the latter situation are given in Table 4. In order
to show the effect of the family sample size on the varia-
tion intervals, we also give the results obtained on the
family sample resulting from pooling the two best repli-
cates (97 and 63; Table 1) and from pooling the five best
replicates (97, 63, 19, 48 and 56; Table 1). We show that
the estimates at the susceptibility allele frequency decrease
with the number of families (0.24 per 1 replicate; 0.20 per
5 replicates). However, the uncertainty on the disease
allele frequency estimate is very large. The size of the var-
iation interval decreases when the sample size increases
mainly by the upper limit. Expected for the largest sample
size (500 families), the size of the variation interval does
not depend on whether the uncertainty on the marker
allele frequencies is taken into account or not.
Discussion
Before knowing the simulation model
We have modeled one susceptibility locus S for KPD using
the diagnosis criteria of the Aipotu population. It is very
likely that the different sub-criteria used for this diagnosis
are not determined by S in the same way. The distribution
of the sub-phenotypes in all the affected and all the unaf-
fected individuals as well as the IBD distribution between
affected sibs in the pooled set of 10,000 families is given
Table 4: Variation interval of the disease allele frequency q
95% Variation interval [range]a
No. Families No uncertainty Uncertainty
100 0.24 [0.01; 0.74] 0.24 [0.01; 0.74]
200 0.22 [0.01; 0.54] 0.22 [0.01; 0.55]
500 0.20 [0.07; 0.35] 0.20 [0.01; 0.35]
a 95% variation interval of the disease allele frequency q when the 
marker allele frequencies are known ("no uncertainty") and when they 
are estimated from the untransmitted parental alleles ("uncertainty").
Table 2: Models compatible with observations made on M in 
replicate 97
λ1 λ2Q χ2 (df)
General 0.02 0.001 0.002 1.852 (4 df)
Dominant 1 0 0.001 5.468 (6 df)
Recessive 0 0 0.249 4.005 (6 df)
Table 1: The 10 best replicates. Chi-squares between the 
distributions observed in the replicate and in the pooled sample.











Table 3: Frequencies of allele 1 for SNPs 16, 17, 18, and 19 for the 
index cases and the controls





16 0.70 0.50 580.84
17 0.40 0.27 258.40
18 0.67 0.54 225.47
19 (marker M) 0.62 0.55 73.61BMC Genetics 2005, 6:S87
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in Table 5. All affected individuals display the sub-pheno-
type combination (e + f + h) compared to only 4‰ of
unaffected individuals. This means that the diagnostic cri-
teria in Aipotu are equivalent to having simultaneously
sub-phenotypes (e + f + h). There is no distortion in the
IBD distribution of sub-phenotypes i, j, and l. In addition,
i and j have the same frequency in affected and unaffected
individuals. The sub-phenotype k shows the strongest IBD
distribution distortion (0.1, 0.49, 0.41 for IBD = 0, 1, 2,
respectively).
The observed distributions do not provide any informa-
tion on the dominant parameter of the disease locus.
Indeed, the 95% variation interval of λ1 ranges from 0 to
1. Information can however be improved by taking into
account the familial recurrence risk for KPD. The propor-
tion of affected parents is 0.2 and the proportion of
affected sibs of indexes is 0.1, after excluding the two sibs
by which the families were ascertained (Table 6). The
recurrence risk is thus twice as high in parent than in sibs,
which cannot be explained by different genetic models,
except different penetrances between the generations.
After knowing the simulation model
To validate our bootstrap procedure, we looked to see if
the true parameters used for the simulation were included
in our variation intervals. The value of the disease allele
frequency used in the simulation is 0.15. This value is
included in the variation intervals for the three sample
sizes we used (100, 200, and 500 families). The larger the
sample size, the closer the estimate to the true value.
Note that the true value of the dominance parameter can-
not be inferred from the provided answers without exten-
sive work. Indeed, the KPD phenotype is a mixture of
different phenotypes, each one corresponding to different
models of interaction between D2 and another suscepti-
bility locus. Because there is no generation effect in the
simulation, we still cannot explain the greater risk for par-
ents than for sibs.
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